Conferences and Events

May 7 - 11, 2024

Baltimore Convention Center | Baltimore, MD

The American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting is the best place for people in the field to learn about the latest scientific research and stay up to date on new technologies. Request a meeting.

May 28 - June 1, 2024

Vancouver Convention Center | Vancouver, Canada

The International Society for Cell & Gene Therapy’s 30th Annual Meeting is a translational-focused program designed to educate, tackle barriers and drive solutions. The event will bring together an expansive network of cell and gene therapies professionals to address obstacles and progress the future of cell and gene therapies to bring scientific innovation to therapeutic reality for patients. Request a meeting.

May 31 - June 4, 2024

McCormick Place | Chicago, IL

Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care. Request a meeting.

In this series, you'll engage directly with experts across Versiti Clinical Trials' extensive range of services and areas of clinical expertise. Delve into crucial topics such as HLA typing, molecular assay development, qPCR validation, central lab management, regulatory and quality compliance, and more. Each session block provides an opportunity to sign up for a 15-minute 1:1 consultation with our esteemed scientists and thought leaders, providing tailored insights and solutions for your specific questions. Join the conversation and elevate your understanding in the ever-evolving landscape of clinical trials.

Hosted by: Doug Rains, Chief Scientific Officer, Quantigen

Join Doug Rains and delve into the intricacies of qPCR and Digital PCR Assay Development and Validation for Clinical Trials. Don't miss this opportunity to gain invaluable insights. Whether you're a seasoned researcher, laboratory professional or a newcomer in the field of molecular diagnostics, this session will equip you with the essential knowledge and insights necessary for advancing your clinical research endeavors.

Friday, April 19; 2:30 - 4:00 p.m. CT

Hosted by: Brandon Harper, Chief Operating Officer, Cenetron Diagnostics

Join Brandon Harper and uncover insights about Supply Chain Disruption: Managing Expectations. Whether you're a central lab supply chain professional or industry stakeholder, this session will provide invaluable guidance for mitigating risks and ensuring operational resilience in an ever-changing global landscape. This session offers a comprehensive examination of the complexities involved in maintaining operational continuity and meeting stakeholders' needs during times of turmoil.

Friday, May 10; 10:00 - 11:30 a.m. CT

Hosted by: Matt Anderson, MD, PhD, Director Clinical Affairs, Versiti

Join Matt Anderson for an in-depth exploration of HLA typing and antibody analysis, focusing on critical factors for consideration in clinical trials. This session will provide a comprehensive overview of the complexities involved in HLA typing and antibody analysis, addressing key topics such as assay selection, sample preparation, data interpretation and regulatory compliance. Gain valuable insights and practical strategies to enhance the efficiency and accuracy of HLA typing and antibody analysis in clinical trial settings.

Friday, May 24; 2:30 – 4:00 p.m. CT

Hosted by: Gretchen Miller-Bowker, Vice President Business Development and Operations, Pearl Pathways & Pearl IRB

Join Gretchen as she discusses the intricate landscape of CMC (chemistry, manufacturing and controls) considerations tailored specifically for cellular therapy. This session promises to unravel the complexities inherent in the development and manufacturing of cellular therapies, covering vital topics such as process optimization, quality control and regulatory compliance. Attendees will gain invaluable insights and practical guidance to address the unique challenges associated with CMC in the realm of cellular therapy, equipping them with the knowledge necessary for advancing innovative treatments in clinical practice.

Friday, June 7; 2:00 - 3:30 p.m. CT

Hosted by: Doug Rains, Chief Scientific Officer, Quantigen

Join Doug Rains for an illuminating discussion focused on the critical aspects of biopharmaceutical quality control within the framework of clinical trials. Delve into the intricacies of maintaining product integrity, safety and efficacy throughout the development and testing phases. This captivating session will address key considerations such as assay validation, batch consistency, regulatory compliance and the implementation of rigorous quality assurance measures. Gain valuable insights into the latest advancements and best practices essential for ensuring the reliability and success of biopharmaceutical interventions in clinical research settings.

Friday, June 21; 2:30 - 4:00 p.m. CT